Skeletal muscle adiposity, coronary microvascular dysfunction, and adverse cardiovascular outcomes
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Background and Aims: Skeletal muscle (SM) fat infiltration, or intermuscular adipose tissue (IMAT), reflects muscle quality and is associated with inflammation, a key determinant in cardiometabolic disease. Coronary flow reserve (CFR), a marker of coronary microvascular dysfunction (CMD), is independently associated with body mass index (BMI), inflammation and risk of heart failure, myocardial infarction, and death. The relationship between SM quality, CMD, and cardiovascular outcomes is not known. Methods: Consecutive patients (n = 669) undergoing evaluation for coronary artery disease with cardiac stress positron emission tomography demonstrating normal perfusion and preserved left ventricular ejection fraction were followed over a median of 6 years for major adverse cardiovascular events (MACEs), including death and hospitalization for myocardial infarction or heart failure. Coronary flow reserve was calculated as stress/rest myocardial blood flow. Subcutaneous adipose tissue (SAT), SM, and IMAT areas (cm2) were obtained from simultaneous positron emission tomography attenuation correction computed tomography using semi-automated segmentation at the 12th thoracic vertebra level. Results: Median age was 63 years, 70% were female, and 46% were nonwhite. Nearly half of patients were obese (46%, BMI 30–61 kg/m2), and BMI correlated highly with SAT and IMAT (r = .84 and r = .71, respectively, P < .001) and moderately with SM (r = .52, P < .001). Decreased SM and increased IMAT, but not BMI or SAT, remained independently associated with decreased CFR (adjusted P = .03 and P = .04, respectively). In adjusted analyses, both lower CFR and higher IMAT were associated with increased MACE [hazard ratio 1.78 (95% confidence interval 1.23–2.58) per −1 U CFR and 1.53 (1.30–1.80) per +10 cm2 IMAT, adjusted P = .002 and P < .0001, respectively], while higher SM and SAT were protective [hazard ratio .89 (.81–.97) per +10 cm2 SM and .94 (.91–.98) per +10 cm2 SAT, adjusted P = .01 and .003, respectively]. Every 1% increase in fatty muscle fraction [IMAT/(SM + IMAT)] conferred an independent 2% increased odds of CMD [CFR <2, odds ratio 1.02 (1.01–1.04), adjusted P = .04] and a 7% increased risk of MACE [hazard ratio 1.07 (1.04–1.09), adjusted P < .001]. There was a significant interaction between CFR and IMAT, not BMI, such that patients with both CMD and fatty muscle demonstrated highest MACE risk (adjusted P = .02). Conclusions: Increased intermuscular fat is associated with CMD and adverse cardiovascular outcomes independently of BMI and conventional risk factors. The presence of CMD and SM fat infiltration identified a novel at-risk cardiometabolic phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Skeletal muscle adiposity has also been associated with adverse cardiovascular outcomes (32).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Obesity and cardiovascular disease: a scientific statement from the American Heart Association
Powell-Wiley, T. M., Poirier, P., Burke, L. E., Després, J.-P., Gordon-Larsen, P., Lavie, C. J., Lear, S. A., Ndumele, C. E., Neeland, I. J., Sanders, P., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000973 · Cited by 3,691
Obesity and the risk of heart failure
Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020245 · Cited by 3,093
Shen, W., Punyanitya, M., Wang, Z., Gallagher, D., St.-Onge, M.-P., Albu, J., Heymsfield, S. B., & Heshka, S. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00744.2004 · Cited by 1,692
Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001168 · Cited by 1,598
Self-citationKhan, S. S., Ning, H., Wilkins, J. T., Allen, N., Carnethon, M., Berry, J. D., Sweis, R. N., & Lloyd-Jones, D. M. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.0022 · Cited by 1,072
Mohammed, S. F., Hussain, S., Mirzoyev, S. A., Edwards, W. D., Maleszewski, J. J., & Redfield, M. M. (2015) · Circulation · doi:10.1161/circulationaha.114.009625 · Cited by 874
Obesity Accelerates the Progression of Coronary Atherosclerosis in Young Men
McGill, H. C., McMahan, C. A., Herderick, E. E., Zieske, A. W., Malcom, G. T., Tracy, R. E., & Strong, J. P. (2002) · Circulation · doi:10.1161/01.cir.0000018121.67607.ce · Cited by 684
Goodpaster, B. H., Krishnaswami, S., Resnick, H., Kelley, D. E., Haggerty, C., Harris, T. B., Schwartz, A. V., Kritchevsky, S., & Newman, A. B. (2003) · Diabetes Care · doi:10.2337/diacare.26.2.372 · Cited by 619
Derstine, B. A., Holcombe, S. A., Ross, B. E., Wang, N. C., Su, G. L., & Wang, S. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-29825-5 · Cited by 507
Research works printed but not linked: 33
- Goodpaster, 2022, Intermuscular adipose tissue in metabolic disease, Nat Rev Endocrinol, 19, 285, 10.1038/s41574-022-00784-2 · DOI · Paper page
- Li, 2012, Co-methylated genes in different adipose depots of pig are associated with metabolic, inflammatory and immune processes, Int J Biol Sci, 8, 831, 10.7150/ijbs.4493 · DOI
- Kahn, 2022, Quantifying the inflammatory secretome of human intermuscular adipose tissue, Physiol Rep, 10, e15424, 10.14814/phy2.15424 · DOI
- Bajaj, 2018, Coronary microvascular dysfunction and cardiovascular risk in obese patients, J Am Coll Cardiol, 72, 707, 10.1016/j.jacc.2018.05.049 · DOI · Paper page
- Taqueti, 2015, Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease, Circulation, 131, 528, 10.1161/CIRCULATIONAHA.114.009716 · DOI · Paper page
- Taqueti, 2018, Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction, Eur Heart J, 39, 840, 10.1093/eurheartj/ehx721 · DOI · Paper page
- Taqueti, 2017, Excess cardiovascular risk in women relative to men referred for coronary angiography is associated with severely impaired coronary flow reserve, not obstructive disease, Circulation, 135, 566, 10.1161/CIRCULATIONAHA.116.023266 · DOI · Paper page
- Taqueti, 2015, Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization, Circulation, 131, 19, 10.1161/CIRCULATIONAHA.114.011939 · DOI · Paper page
- Zhou, 2020, Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure, Eur Heart J, 41, 2366, 10.1093/eurheartj/ehaa191 · DOI
- Vita, 2019, Association between nonalcoholic fatty liver disease at CT and coronary microvascular dysfunction at myocardial perfusion PET/CT, Radiology, 291, 330, 10.1148/radiol.2019181793 · DOI · Paper page
- Taqueti, 2023, Coronary flow reserve, inflammation, and myocardial strain: the CIRT-CFR trial, JACC Basic Transl Sci, 8, 141, 10.1016/j.jacbts.2022.08.009 · DOI
- Taqueti, 2013, Inflammation, coronary flow reserve, and microvascular dysfunction: moving beyond cardiac syndrome X, JACC Cardiovasc Imaging, 6, 668, 10.1016/j.jcmg.2013.02.005 · DOI
- Osborne, 2017, Coronary microvascular dysfunction identifies patients at high risk of adverse events across cardiometabolic diseases, J Am Coll Cardiol, 70, 2835, 10.1016/j.jacc.2017.09.1104 · DOI
- Shah, 2017, Ranolazine in symptomatic diabetic patients without obstructive coronary artery disease: impact on microvascular and diastolic function, J Am Heart Assoc, 6, e005027, 10.1161/JAHA.116.005027 · DOI
- El Fakhri, 2009, Reproducibility and accuracy of quantitative myocardial blood flow assessment with (82)Rb PET: comparison with (13)N-ammonia PET, J Nucl Med, 50, 1062, 10.2967/jnumed.104.007831 · DOI · Paper page
- Tan, 2021, Diagnosing sarcopenia and myosteatosis based on chest computed tomography images in healthy Chinese adults, Insights Imaging, 12, 163, 10.1186/s13244-021-01106-2 · DOI
- Fuchs, 2018, Quantifying the effect of slice thickness, intravenous contrast and tube current on muscle segmentation: implications for body composition analysis, Eur Radiol, 28, 2455, 10.1007/s00330-017-5191-3 · DOI
- Troschel, 2021, Significance of acquisition parameters for adipose tissue segmentation on CT images, AJR Am J Roentgenol, 217, 177, 10.2214/AJR.20.23280 · DOI
- Bridge, 2022, A fully automated deep learning pipeline for multi-vertebral level quantification and characterization of muscle and adipose tissue on chest CT scans, Radiol Artif Intell, 4, e210080, 10.1148/ryai.210080 · DOI
- Foldyna, 2020, Epicardial adipose tissue in patients with stable chest pain: insights from the PROMISE trial, JACC Cardiovasc Imaging, 13, 2273, 10.1016/j.jcmg.2020.05.024 · DOI
- Thygesen, 2018, Fourth universal definition of myocardial infarction (2018), Circulation, 138, e618, 10.1161/CIR.0000000000000617 · DOI · Paper page
- Ong, 2018, International standardization of diagnostic criteria for microvascular angina, Int J Cardiol, 250, 16, 10.1016/j.ijcard.2017.08.068 · DOI · Paper page
- Taqueti, 2018, Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC state-of-the-art review, J Am Coll Cardiol, 72, 2625, 10.1016/j.jacc.2018.09.042 · DOI · Paper page
- Morise, 1997, Development and validation of a clinical score to estimate the probability of coronary artery disease in men and women presenting with suspected coronary disease, Am J Med, 102, 350, 10.1016/S0002-9343(97)00086-7 · DOI · Paper page
- Reynolds, 2022, Coronary arterial function and disease in women with no obstructive coronary arteries, Circ Res, 130, 529, 10.1161/CIRCRESAHA.121.319892 · DOI
- Kammerlander, 2021, Sex differences in the associations of visceral adipose tissue and cardiometabolic and cardiovascular disease risk: the Framingham Heart Study, J Am Heart Assoc, 10, e019968, 10.1161/JAHA.120.019968 · DOI · Paper page
- Taqueti, 2024, Semaglutide and cardiovascular outcomes, N Engl J Med, 390, 766, 10.1056/NEJMc2400414 · DOI
- Yim, 2007, Intermuscular adipose tissue rivals visceral adipose tissue in independent associations with cardiovascular risk, Int J Obes, 31, 1400, 10.1038/sj.ijo.0803621 · DOI
- Terry, 2017, Intermuscular adipose tissue and subclinical coronary artery calcification in midlife: the CARDIA study (Coronary Artery Risk Development in Young Adults), Arterioscler Thromb Vasc Biol, 37, 2370, 10.1161/ATVBAHA.117.309633 · DOI · Paper page
- Molina, 2016, Skeletal muscle mitochondrial content, oxidative capacity, and Mfn2 expression are reduced in older patients with heart failure and preserved ejection fraction and are related to exercise intolerance, JACC Heart Fail, 4, 636, 10.1016/j.jchf.2016.03.011 · DOI · Paper page
- Souza, 2024, Body composition, coronary microvascular dysfunction, and future risk of cardiovascular events including heart failure, JACC Cardiovasc Imaging, 17, 179, 10.1016/j.jcmg.2023.07.014 · DOI
- Diaz-Canestro, 2022, Lean body mass and the cardiovascular system constitute a female-specific relationship, Sci Transl Med, 14, eabo2641, 10.1126/scitranslmed.abo2641 · DOI
- Zhang, 2022, Body composition and incident heart failure in older adults: results from 2 prospective cohorts, J Am Heart Assoc, 11, e023707, 10.1161/JAHA.121.023707 · DOI
Cited by
Glucagon-like peptide-1 receptor agonists and muscle mass effects
Ceasovschih, A., Asaftei, A., Lupo, M. G., Kotlyarov, S., Bartušková, H., Balta, A., Sorodoc, V., Sorodoc, L., & Banach, M. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107927 · Cited by 64
Wu, Q., Yang, F., An, Q., Liu, Y., Tian, H., Du, Y., Cai, W., Lei, M., Xu, J., Deng, L., et al. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.126.049987
Sung, S., Choi, H. J., Jeong, S., Cho, W., Kim, Y. J., Cha, H., Min, C. H., & Kim, M. S. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1946212
Metadata
- Authors
- Souza, A. C. D. A. H., Troschel, A. S., Marquardt, J. P., Hadžić, I., Foldyna, B., Moura, F. A., Hainer, J., Divakaran, S., Blankstein, R., Dorbala, S., Di Carli, M. F., Aerts, H. J. W. L., Lu, M. T., Fintelmann, F. J., & Taqueti, V. R.
- Affiliations
- Cardiovascular Imaging Program, Brigham and Women’s Hospital , Harvard Medical School, 75 Francis St., Boston, MA 02115 ,
- Division of Thoracic Imaging, Department of Radiology, Massachusetts General Hospital , Boston, MA 02114 ,
- Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School , Boston, MA 02114 ,
- Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School , Boston, MA 02114 ,
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2025-01-20
- Volume
- 46
- Issue
- 12
- Pages
- 1112-1123
- ISSN
- 0195-668X
- 1522-9645
- Cited by
- 68
- References
- 12
- Language
- en
- Funders
- Lemann Cardiovascular Research Fellowship
- Gilead Sciences Research Scholars Program in Cardiovascular Disease
- NIH (K23HL135438)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Skeletal muscle adiposity, coronary microvascular dysfunction, and adverse cardiovascular outcomes. https://app.cochat.ai/papers/10.1093/eurheartj/ehae827
- The paper
- Souza, A. C. D. A. H., Troschel, A. S., Marquardt, J. P., Hadžić, I., Foldyna, B., Moura, F. A., Hainer, J., Divakaran, S., Blankstein, R., Dorbala, S., Di Carli, M. F., Aerts, H. J. W. L., Lu, M. T., Fintelmann, F. J., & Taqueti, V. R. (2025). Skeletal muscle adiposity, coronary microvascular dysfunction, and adverse cardiovascular outcomes. European Heart Journal. https://doi.org/10.1093/eurheartj/ehae827
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.